David Eichenbaum, MD, spoke with Modern Retina to provide and overview on his presentation at ASRS 2024 and the current state of geographic atrophy treatment.
Modern Retina Fall 2024
Dilsher Dhoot, MD, sat down with Modern Retina to provide some insights on the phase 1 HELIOS trial, which he presented on during the 2024 ASRS meeting held in Stockholm, Sweden earlier in 2024.
Digital exclusive article on red-blue-green ultrawidefield (UWF) imaging
“[Gene therapy may] dramatically reduce frequency of treatments.”
A look back at the 2024 ASRS conference held in Sweden
Pearls from PULSAR, PHOTON, and working practitioners
Zhang’s journey as the first retina optometrist in Colorado
Gene therapy offers a promising alternative by potentially providing long-lasting effects from a single treatment.
Retina is a rapidly advancing field with promising research, technology, and treatment areas. Two stand out as particularly exciting.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Port Delivery System Therapies in Retinal Vascular Diseases
2
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
3
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
4
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
5